Circulating ORF1p (first generation Simoa assay) versus prostate-specific antigen (PSA).
No takes yet. Share an insight, caveat, or question.
Taylor et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: